Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Bullboard Posts
Comment by jlunminon Apr 17, 2015 1:08pm
124 Views
Post# 23641022

RE:From Zack's...

RE:From Zack's...
calenderj wrote: We continue to believe that Immune has enormous upside potential based on the development of bertilimumab and the potential to partner AmiKet over the near-term. We are maintaining our 'Buy' rating and our price target of $6 per share



$6 per share = $4 million for the 655K shares and $400K for the 123K warrants at a strike price of $2.63. So $6.4 million JUST for the value of IMNP stock and that's where the market cap of ICO is right now at 7.5 cents. 

Of course IMNP has a while to go to get to $6 but that just goes to show you how much upside ICO has. Presumably IMNP will only get to $6 upon success and if they are successful iCO-008 is worth a lot more because ICO licensed it out to IMNP for certain diseases but is keeping it for many others and success in one, like FDA approval, really helps the chances for future successes elsewhere. 


Bullboard Posts